Status:
UNKNOWN
IL2 Imaging in Renal Transplantation
Lead Sponsor:
University Medical Center Groningen
Conditions:
Kidney Transplant Rejection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
After renal transplantation 5 to 10% of patients experience allograft rejection. Rapid and accurate diagnosis is vital for implementation of additional immunosuppressive therapy. Currently, a renal bi...
Eligibility Criteria
Inclusion
- Female or male aged between 18 and 80 years.
- Renal Transplant recipients
- The patient understands the purpose and risks of the study and has given written informed consent to participate in the study.
- All patients will have a clinical indication for renal biopsy.
Exclusion
- Patients with multiple-organ transplants.
- Female patients who are pregnant or unwilling to use adequate contraception during the study.
- Claustrophobia
- Altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.
- A clinical reason for an immediate start of a therapeutic intervention with immunosuppressive medication.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03304223
Start Date
December 1 2017
End Date
December 1 2023
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands